Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice

BACKGROUND: Though there are several classes of antidepressant drugs available on the pharmaceutical market, depression that affects globally over 320 million people is still undertreated. Scientists have made attempts to develop novel therapeutical strategies to maximize effectiveness of therapy an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pharmacol Rep
Autores principales: Poleszak, Ewa, Wośko, Sylwia, Sławińska, Karolina, Wyska, Elżbieta, Szopa, Aleksandra, Świąder, Katarzyna, Wróbel, Andrzej, Szponar, Jarosław, Doboszewska, Urszula, Wlaź, Piotr, Wlaź, Aleksandra, Serefko, Anna
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2020
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7704509/
https://ncbi.nlm.nih.gov/pubmed/32221841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s43440-020-00088-0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares